Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: Recently, intrinsic sphincter deficiency (ISD) has been identified as one important factor in the outcome of stress urinary incontinence (SUI) related surgery. Clinical factors that can predict ISD are uncommon. The aim of this study was to determine predictive clinical factors for ISD in female patients with SUI.
Methods: The patients were classified into 3 groups according to the value of Valsalva leak point pressure (VLPP)>90 cm HO (anatomical incontinence, AI), between 61 and 90 cm HO (equivocal, EV), and <60 cm HO (ISD). All groups underwent a full examination, history evaluation, physical examination, uroflowmetry, and complete urodynamic study. Univariate analysis was performed by chi-square or t-test for categorical variables, respectively. A multivariate study was performed by Pearson correlation analysis in order to get clinical predictors of VLPP<60 cm HO. Statistical significance was set at P<0.05.
Results: There were 3 groups with a total of 189 patients: 56 patients (AI, 29.7%), 64 patients (EV, 33.8%), and 69 patients (ISD, 36.5%). The univariate analysis revealed a significant difference associated with maximal urethral closing pressure (P=0.03) and Stamey classification (P=0.006) between ISD and AI. The more severe the urinary symptom grade, the higher the frequency of ISD. However, the multivariate analysis showed the independent predictor of ISD is only present in grades II and III symptoms in the Stamey classification (P=0.001).
Conclusions: It was found that the more severe the symptoms of urinary incontinence, the higher the possibility of ISD. In other words, the degree of urinary incontinence was found to be one relevant clinical factor in predicting ISD. This finding may help in evaluating and identifying the appropriate surgical technique for EV. Currently, absolute cutoff value to diagnose ISD has not yet been determined. More research is needed to identify clinical factors that can predict ISD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497197 | PMC |
| http://dx.doi.org/10.5213/inj.1732710.355 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Healing with precision - Robotic Mitrofanoff procedure with autologous pubovaginal sling in neurogenic incontinence.
Indian J Urol
July 2025
Department of Urology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
A 21-year-old obese female presented with urinary incontinence and lower limb weakness after a D11-L3 laminectomy for spinal teratoma. Evaluation revealed a patulous urethra with video-urodynamic study suggestive of hyposensory, hypocontractile bladder of 500 ml capacity with open bladder neck, intrinsic sphincter deficiency, and good compliance. Due to obesity, perineal hypoesthesia, and clean intermittent catheterization (CIC) challenges, a robotic Mitrofanoff channel and continent bladder neck (tensor fascia lata graft) were planned.
View Article and Find Full Text PDFBackground: AUS implantation is the standard treatment recommended by the European Urological Association and American Urological Association guidelines to treat stress urinary incontinence due to intrinsic sphincter deficiency. AUS implantation following a neobladder construction or urethroplasty has been previously reported; however, there are only a few reports on patients who have undergone both procedures.This report presents a unique case of a patient who underwent artificial urinary sphincter (AUS) implantation after undergoing both urethroplasty and ileal neobladder construction.
View Article and Find Full Text PDFTransurethral Sphincterotomy and an Artificial Urinary Sphincter - A Novel 2-Stage Surgery for Refractory Bladder Emptying Disorders: A Proof-of-Concept Study.
Int Neurourol J
June 2025
Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Purpose: We developed an innovative 2-stage procedure combining transurethral sphincterotomy (TURS) with artificial urinary sphincter (AUS) implantation to restore voiding in patients with refractory bladder emptying disorders. This proof-of-concept study evaluated its safety and efficacy.
Methods: We retrospectively reviewed clinical data from patients who underwent combined TURS and AUS implantation between April 7, 2021, and October 31, 2024.
Critical Appraisal of Evidence on Platelet-Rich Plasma and Stem Cell Therapy for Stress Urinary Incontinence: A Narrative Review.
Cureus
May 2025
Department of Endourology and Reconstructive Urology, Mersey and West Lancashire Teaching Hospitals NHS Trust, Liverpool, GBR.
Stress urinary incontinence (SUI) is a common condition, affecting 20% of individuals. It is defined by the involuntary loss of urine during activities that increase intra-abdominal pressure, such as coughing or physical exertion. SUI may result from urethral hypermobility or intrinsic sphincter deficiency.
View Article and Find Full Text PDFFive-Year Follow-up Study on Safety and Efficacy of Macroplastique® in Female Patients with Stress Urinary Incontinence (the ROSE Study).
Int Urogynecol J
June 2025
Aswan University, Aswan, Egypt.
Introduction And Hypothesis: This study presents the 5-year study close-out results from the Real-Time Observation of Safety and Effectiveness (ROSE) study, evaluating the safety and efficacy of the Macroplastique® (MPQ) urethral bulking agent for the treatment of stress urinary incontinence (SUI) in women with intrinsic sphincter deficiency (ISD).
Methods: The ROSE study was an observational prospective study conducted at 22 US centers that enrolled 274 adult women with ISD-confirmed SUI. Participants underwent MPQ treatment with an option for repeat injections.